Conclusion The Medicare GLP-1 Bridge represents a significant effort to make innovative, but expensive medications, more accessible to seniors
Visible improvements typically appear after 3 to 4 treatments
Type II diabetics with excessively high blood sugar are also at a greater risk of heart attack and stroke
Well, lets break that all down
Keywords: Glucagon-like peptide-1 receptor agonists, Dipeptidyl peptidase-4 inhibitors, Type 2 diabetes mellitus, Cardiovascular outcome Background Type 2 diabetes mellitus (T2DM), a common metabolic disorder characterized by insulin resistance and inadequate insulin secretion by pancreatic cells, has become a growing cause of morbidity and mortality worldwide
But in a third of the studies they analyzed, no healthy young adults experienced any cognitive improvement with the drugs, and some even experienced impairments